Effects of Hovenia dulcis fruit and peduncle extract on alcohol metabolism.

Alcohol dehydrogenase Aldehyde dehydrogenase Dihydromyricetin Hovenia dulcis fruit and peduncle

Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
03 Dec 2023
Historique:
received: 27 06 2023
revised: 27 11 2023
accepted: 30 11 2023
pubmed: 6 12 2023
medline: 6 12 2023
entrez: 5 12 2023
Statut: aheadofprint

Résumé

The dried fruit and peduncle of Hovenia dulcis Thunberg (Rhamnaceae) (HD) has been used as a folk medicine to treat liver disease, detoxify alcoholism, and prevent and cure hangovers. We investigated the pharmacology of HD on the kinetics of EtOH and on the enzymes related to alcohol metabolism to seek the scientific evidence of HD to prevent hangover, the effectiveness as a folk medicine. EtOH was orally administered 30 min after oral administration of HD boiling water extract in rats. Then, the profiles of blood EtOH concentrations were measured. Mice were reared with food containing powdered HD for 7 days, and the activities of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in liver were measured. Hepa1c1c7 cells were cultured with the medium containing HD extract, and the activities of ADH and ALDH were measured. HD extract reduced the blood EtOH concentrations in rats and induced the activities of ADH and ALDH and mRNA and protein expressions of ADH1B, ALDH1A1, and ALDH2 in the liver of mice and Hepa1c1c7 cells. Dihydromyricetin, one of the ingredients of HD, significantly induced the activities of ADH and ALDH in Hepa1c1c7 cells, however, the fractions containing hydrophilic organic compounds with small molecular weight contributed the most of the activities of HD extract. We clarified the experimental pharmacological evidences of HD as a folk medicine to detoxify alcoholism and prevent hangovers.

Identifiants

pubmed: 38052412
pii: S0378-8741(23)01411-3
doi: 10.1016/j.jep.2023.117541
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117541

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: T.M. received grant support from Kuki Sangyo, Tsumura, Kracie Pharmaceutical, Taisho Pharmaceutical, and Kobayashi Pharmaceutical. Y.S. and T.O. are the employees of Matsuura Yakugyo.

Auteurs

Madoka Niiya (M)

Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan. Electronic address: pooooh.218@outlook.jp.

Yota Shimato (Y)

Matsuura Yakugyo Co., Ltd., 24-21 Enjo-cho, Showa-ku, Nagoya, 466-0054, Japan. Electronic address: y-shimato@matsuura-gp.co.jp.

Takamasa Ohno (T)

Matsuura Yakugyo Co., Ltd., 24-21 Enjo-cho, Showa-ku, Nagoya, 466-0054, Japan. Electronic address: takamasa-ohno@matsuura-gp.co.jp.

Toshiaki Makino (T)

Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan.

Classifications MeSH